CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: kojic acid
Accession: CHEBI:43572
browse the term
Definition: A pyranone that is 4H-pyran substituted by a hydroxy group at position 5, a hydroxymethyl group at position 2 and an oxo group at position 4. It has been isolated from the fungus Aspergillus oryzae.
Synonyms: exact_synonym: 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one
related_synonym: 5-hydroxy-2-hydroxymethyl-4-pyrone; Formula=C6H6O4; InChI=1S/C6H6O4/c7-2-4-1-5(8)6(9)3-10-4/h1,3,7,9H,2H2; InChIKey=BEJNERDRQOWKJM-UHFFFAOYSA-N; Kojisaeure; SMILES=OCc1cc(=O)c(O)co1; acido kojico
alt_id: CHEBI:34805; CHEBI:43568
xref: Beilstein:120895; CAS:501-30-4; DrugBank:DB01759; Drug_Central:3977; Gmelin:3620; HMDB:HMDB0032923; KEGG:C14516
xref_mesh: MESH:C011890
xref: MetaCyc:KOJIC-ACID; PDBeChem:KOJ; PMID:11534762; PMID:1348188; PMID:15039076; PMID:16198580; PMID:18083129; PMID:19471877; PMID:20943172; PMID:23683589; PMID:24116376; PMID:28166217; PMID:7714722; PMID:8987542; Patent:AU2012268879; Patent:JP2013017408; Reaxys:120895; Wikipedia:Kojic_acid
G
2810004N23Rik
RIKEN cDNA 2810004N23 gene
decreases expression
ISO
kojic acid results in decreased expression of C1ORF131 mRNA
CTD
PMID:16595896
NCBI chr 8:125,566,094...125,589,768
Ensembl chr 8:125,563,684...125,589,859
G
Abca13
ATP-binding cassette, sub-family A member 13
decreases expression
ISO
kojic acid results in decreased expression of ABCA13 mRNA
CTD
PMID:16595896
NCBI chr11:9,141,942...9,634,871
Ensembl chr11:9,141,942...9,634,259
G
Abcc2
ATP-binding cassette, sub-family member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of ABCC2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC2 mRNA
CTD
PMID:18544905
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc6
ATP-binding cassette, sub-family C member 6
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC6 mRNA [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC6 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
G
Abcc9
ATP-binding cassette, sub-family C member 9
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC9 mRNA
CTD
PMID:17917374
NCBI chr 6:142,533,592...142,648,472
Ensembl chr 6:142,533,588...142,648,041
G
Abcd1
ATP-binding cassette, sub-family D member 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCD1 mRNA
CTD
PMID:17917374
NCBI chr X:72,760,203...72,782,140
Ensembl chr X:72,760,203...72,782,140
G
Abcf2
ATP-binding cassette, sub-family F member 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA
CTD
PMID:17917374
NCBI chr 5:24,770,339...24,782,465
Ensembl chr 5:24,770,343...24,782,465
G
Abhd1
abhydrolase domain containing 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABHD1 mRNA
CTD
PMID:17917374
NCBI chr 5:31,107,410...31,112,439
Ensembl chr 5:31,107,410...31,112,435
G
Acer3
alkaline ceramidase 3
increases expression
ISO
kojic acid results in increased expression of ACER3 mRNA
CTD
PMID:16595896
NCBI chr 7:97,863,015...97,970,415
Ensembl chr 7:97,855,596...97,970,415
G
Acmsd
amino carboxymuconate semialdehyde decarboxylase
decreases expression
ISO
kojic acid results in decreased expression of ACMSD mRNA
CTD
PMID:16595896
NCBI chr 1:127,657,149...127,695,723
Ensembl chr 1:127,657,150...127,695,715
G
Acvrl1
activin A receptor, type II-like 1
decreases expression
ISO
kojic acid results in decreased expression of ACVRL1 mRNA
CTD
PMID:16595896
NCBI chr15:101,026,403...101,043,217
Ensembl chr15:101,026,403...101,043,217
G
Adam20
a disintegrin and metallopeptidase domain 20
decreases expression
ISO
kojic acid results in decreased expression of ADAM20 mRNA
CTD
PMID:16595896
NCBI chr 8:41,246,310...41,250,379
Ensembl chr 8:41,246,310...41,250,340
G
Adrb3
adrenergic receptor, beta 3
decreases expression
ISO
kojic acid results in decreased expression of ADRB3 mRNA
CTD
PMID:16595896
NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644
G
Agap3
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
increases expression
ISO
kojic acid results in increased expression of AGAP3 mRNA
CTD
PMID:16595896
NCBI chr 5:24,657,175...24,707,045
Ensembl chr 5:24,657,175...24,707,045
G
Agbl4
ATP/GTP binding protein-like 4
decreases expression
ISO
kojic acid results in decreased expression of AGBL4 mRNA
CTD
PMID:16595896
NCBI chr 4:110,254,823...111,521,521
Ensembl chr 4:110,254,858...111,521,521
G
Ahnak
AHNAK nucleoprotein
decreases expression
ISO
kojic acid results in decreased expression of AHNAK mRNA
CTD
PMID:16595896
NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278
G
Akt1
thymoma viral proto-oncogene 1
decreases expression
ISO
kojic acid results in decreased expression of AKT1 mRNA
CTD
PMID:16595896
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Alpi
alkaline phosphatase, intestinal
decreases expression
ISO
kojic acid results in decreased expression of ALPI mRNA
CTD
PMID:16595896
NCBI chr 1:87,025,724...87,029,328
Ensembl chr 1:87,025,724...87,029,328
G
Amtn
amelotin
decreases expression
ISO
kojic acid results in decreased expression of AMTN mRNA
CTD
PMID:16595896
NCBI chr 5:88,523,967...88,533,775
Ensembl chr 5:88,523,967...88,533,775
G
Anxa1
annexin A1
decreases expression
ISO
kojic acid results in decreased expression of ANXA1 mRNA
CTD
PMID:16595896
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Anxa5
annexin A5
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA
CTD
PMID:17917374
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Ap1s1
adaptor protein complex AP-1, sigma 1
decreases expression
ISO
kojic acid results in decreased expression of AP1S1 mRNA
CTD
PMID:16595896
NCBI chr 5:137,063,852...137,074,917
Ensembl chr 5:137,063,847...137,074,989
G
Apobec1
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
decreases expression
ISO
kojic acid results in decreased expression of APOBEC1 mRNA
CTD
PMID:16595896
NCBI chr 6:122,554,755...122,580,068
Ensembl chr 6:122,554,751...122,579,403
G
App
amyloid beta precursor protein
increases expression
ISO
kojic acid results in increased expression of APP mRNA
CTD
PMID:16595896
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Aptx
aprataxin
decreases expression
ISO
kojic acid results in decreased expression of APTX mRNA
CTD
PMID:16595896
NCBI chr 4:40,682,078...40,703,206
Ensembl chr 4:40,682,382...40,703,194
G
Aqp1
aquaporin 1
increases expression
ISO
kojic acid results in increased expression of AQP1 mRNA
CTD
PMID:16595896
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
G
Arfip2
ADP-ribosylation factor interacting protein 2
decreases expression
ISO
kojic acid results in decreased expression of ARFIP2 mRNA
CTD
PMID:16595896
NCBI chr 7:105,283,408...105,289,623
Ensembl chr 7:105,283,410...105,289,623
G
Arhgef16
Rho guanine nucleotide exchange factor 16
decreases expression
ISO
kojic acid results in decreased expression of ARHGEF16 mRNA
CTD
PMID:16595896
NCBI chr 4:154,362,926...154,384,535
Ensembl chr 4:154,362,943...154,386,133
G
Arl6ip5
ADP-ribosylation factor-like 6 interacting protein 5
increases expression
ISO
kojic acid results in increased expression of ARL6IP5 mRNA
CTD
PMID:16595896
NCBI chr 6:97,187,753...97,210,276
Ensembl chr 6:97,187,650...97,210,276
G
Asnsd1
asparagine synthetase domain containing 1
decreases expression
ISO
kojic acid results in decreased expression of ASNSD1 mRNA
CTD
PMID:16595896
NCBI chr 1:53,383,776...53,391,911
Ensembl chr 1:53,364,666...53,391,826 Ensembl chr 1:53,364,666...53,391,826
G
Atf6b
activating transcription factor 6 beta
decreases expression
ISO
kojic acid results in decreased expression of ATF6B mRNA
CTD
PMID:16595896
NCBI chr17:34,866,120...34,874,048
Ensembl chr17:34,866,120...34,874,048
G
Atm
ataxia telangiectasia mutated
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ATM mRNA
CTD
PMID:17917374
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
B4galnt4
beta-1,4-N-acetyl-galactosaminyl transferase 4
decreases expression
ISO
kojic acid results in decreased expression of B4GALNT4 mRNA
CTD
PMID:16595896
NCBI chr 7:140,640,891...140,652,313
Ensembl chr 7:140,641,017...140,652,313
G
Bag5
BCL2-associated athanogene 5
decreases expression
ISO
kojic acid results in decreased expression of BAG5 mRNA
CTD
PMID:16595896
NCBI chr12:111,675,922...111,679,690
Ensembl chr12:111,675,922...111,679,691
G
BC028528
cDNA sequence BC028528
increases expression
ISO
kojic acid results in increased expression of C1ORF54 mRNA
CTD
PMID:16595896
NCBI chr 3:95,789,665...95,800,186
Ensembl chr 3:95,791,266...95,799,317
G
Bcl2a1b
B cell leukemia/lymphoma 2 related protein A1b
increases expression
ISO
kojic acid results in increased expression of BCL2A1 mRNA
CTD
PMID:16595896
NCBI chr 9:89,081,326...89,089,891
Ensembl chr 9:89,081,262...89,089,880
G
Bcl2l2
BCL2-like 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA
CTD
PMID:17917374
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression
ISO
kojic acid results in decreased expression of BIRC2 mRNA
CTD
PMID:16595896
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
G
Bmp5
bone morphogenetic protein 5
decreases expression
ISO
kojic acid results in decreased expression of BMP5 mRNA
CTD
PMID:16595896
NCBI chr 9:75,682,647...75,807,598
Ensembl chr 9:75,682,646...75,807,592
G
Brsk1
BR serine/threonine kinase 1
decreases expression
ISO
kojic acid results in decreased expression of BRSK1 mRNA
CTD
PMID:16595896
NCBI chr 7:4,693,635...4,718,996
Ensembl chr 7:4,693,603...4,718,996
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
kojic acid results in decreased expression of BST2 mRNA
CTD
PMID:16595896
NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
G
Cab39l
calcium binding protein 39-like
increases expression
ISO
kojic acid results in increased expression of CAB39L mRNA
CTD
PMID:16595896
NCBI chr14:59,678,400...59,786,353
Ensembl chr14:59,678,421...59,823,213
G
Calr
calreticulin
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA
CTD
PMID:18544905
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
G
Car13
carbonic anhydrase 13
increases expression
EXP
kojic acid results in increased expression of CAR13 mRNA
CTD
PMID:19000923
NCBI chr 3:14,706,787...14,728,062
Ensembl chr 3:14,706,787...14,728,062
G
Car14
carbonic anhydrase 14
increases expression
ISO
kojic acid results in increased expression of CA14 mRNA
CTD
PMID:16595896
NCBI chr 3:95,805,080...95,812,443
Ensembl chr 3:95,805,080...95,812,003
G
Casp4
caspase 4, apoptosis-related cysteine peptidase
multiple interactions
ISO
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA]
CTD
PMID:18544905
NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
G
Casp8
caspase 8
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA
CTD
PMID:18544905
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CAT mRNA
CTD
PMID:18544905
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccar1
cell division cycle and apoptosis regulator 1
increases expression
ISO
kojic acid results in increased expression of CCAR1 mRNA
CTD
PMID:16595896
NCBI chr10:62,579,707...62,628,147
Ensembl chr10:62,579,707...62,628,065
G
Ccdc50
coiled-coil domain containing 50
increases expression
ISO
kojic acid results in increased expression of CCDC50 mRNA
CTD
PMID:16595896
NCBI chr16:27,205,815...27,270,968
Ensembl chr16:27,207,619...27,270,968
G
Ccl21a
C-C motif chemokine ligand 21 (serine)
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL21A mRNA
CTD
PMID:17917374
NCBI chr 4:42,772,860...42,773,991
Ensembl chr 4:42,772,860...42,773,993
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL3 mRNA
CTD
PMID:17917374
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccnb1
cyclin B1
increases expression
EXP
kojic acid results in increased expression of CCNB1 mRNA
CTD
PMID:19000923
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
G
Ccnc
cyclin C
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNC mRNA
CTD
PMID:17917374
NCBI chr 4:21,727,705...21,759,917
Ensembl chr 4:21,727,701...21,759,922
G
Ccnd1
cyclin D1
multiple interactions
ISO EXP
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CCND1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCND1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccng1
cyclin G1
multiple interactions
ISO EXP
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of CCNG1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNG1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
G
Ccpg1
cell cycle progression 1
decreases expression
ISO
kojic acid results in decreased expression of CCPG1 mRNA
CTD
PMID:16595896
NCBI chr 9:72,892,692...72,923,622
Ensembl chr 9:72,892,711...72,923,622
G
Ccr4
C-C motif chemokine receptor 4
decreases expression
ISO
kojic acid results in decreased expression of CCR4 mRNA
CTD
PMID:16595896
NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
G
Cd22
CD22 antigen
decreases expression
ISO
kojic acid results in decreased expression of CD22 mRNA
CTD
PMID:16595896
NCBI chr 7:30,564,829...30,579,767
Ensembl chr 7:30,564,827...30,579,767
G
Cd274
CD274 antigen
increases expression
ISO
kojic acid results in increased expression of CD274 mRNA
CTD
PMID:16595896
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd3g
CD3 antigen, gamma polypeptide
decreases expression
ISO
kojic acid results in decreased expression of CD3G mRNA
CTD
PMID:16595896
NCBI chr 9:44,880,870...44,891,729
Ensembl chr 9:44,880,870...44,891,729
G
Cdin1
CDAN1 interacting nuclease 1
increases expression
ISO
kojic acid results in increased expression of CDIN1 mRNA
CTD
PMID:16595896
NCBI chr 2:115,411,388...115,609,263
Ensembl chr 2:115,412,197...115,609,249
G
Cdk10
cyclin dependent kinase 10
decreases expression
ISO
kojic acid results in decreased expression of CDK10 mRNA
CTD
PMID:16595896
NCBI chr 8:123,951,580...123,958,995
Ensembl chr 8:123,951,581...123,958,989
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA
CTD
PMID:18544905
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
ISO
kojic acid results in decreased expression of CEACAM1 mRNA
CTD
PMID:16595896
NCBI chr 7:25,161,127...25,177,072
Ensembl chr 7:25,161,132...25,177,028
G
Cebpd
CCAAT/enhancer binding protein delta
increases expression
ISO
kojic acid results in increased expression of CEBPD mRNA
CTD
PMID:16595896
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Cenpq
centromere protein Q
decreases expression
ISO
kojic acid results in decreased expression of CENPQ mRNA
CTD
PMID:16595896
NCBI chr17:41,231,700...41,247,637
Ensembl chr17:41,233,942...41,245,938
G
Cep192
centrosomal protein 192
increases expression
ISO
kojic acid results in increased expression of CEP192 mRNA
CTD
PMID:16595896
NCBI chr18:67,933,124...68,018,241
Ensembl chr18:67,933,177...68,018,241
G
Cep72
centrosomal protein 72
increases expression
ISO
kojic acid results in increased expression of CEP72 mRNA
CTD
PMID:16595896
NCBI chr13:74,184,351...74,210,439
Ensembl chr13:74,184,619...74,210,418
G
Ces1d
carboxylesterase 1D
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of CES1 mRNA
CTD
PMID:18544905
NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
G
Chek2
checkpoint kinase 2
multiple interactions
ISO
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA]
CTD
PMID:18544905
NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
G
Chst4
carbohydrate sulfotransferase 4
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CHST4 mRNA
CTD
PMID:17917374
NCBI chr 8:110,755,776...110,766,033
Ensembl chr 8:110,755,785...110,766,372
G
Cibar1
CBY1 interacting BAR domain containing 1
increases expression
ISO
kojic acid results in increased expression of CIBAR1 mRNA
CTD
PMID:16595896
NCBI chr 4:12,153,142...12,172,047
Ensembl chr 4:12,153,409...12,172,015
G
Cldn3
claudin 3
decreases expression
ISO
kojic acid results in decreased expression of CLDN3 mRNA
CTD
PMID:16595896
NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326
G
Cldnd2
claudin domain containing 2
decreases expression
ISO
kojic acid results in decreased expression of CLDND2 mRNA
CTD
PMID:16595896
NCBI chr 7:43,090,164...43,093,554
Ensembl chr 7:43,090,206...43,092,758
G
Clec4b1
C-type lectin domain family 4, member b1
decreases expression
ISO
kojic acid results in decreased expression of CLEC4C mRNA
CTD
PMID:16595896
NCBI chr 6:123,026,921...123,048,514
Ensembl chr 6:123,026,921...123,048,514
G
Clmp
CXADR-like membrane protein
decreases expression
ISO
kojic acid results in decreased expression of CLMP mRNA
CTD
PMID:16595896
NCBI chr 9:40,596,975...40,696,849
Ensembl chr 9:40,597,258...40,696,615
G
Clu
clusterin
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CLU mRNA
CTD
PMID:18544905
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cnih1
cornichon family AMPA receptor auxiliary protein 1
increases expression
ISO
kojic acid results in increased expression of CNIH1 mRNA
CTD
PMID:16595896
NCBI chr14:47,013,024...47,025,814
Ensembl chr14:47,013,024...47,025,868
G
Cnksr2
connector enhancer of kinase suppressor of Ras 2
decreases expression
ISO
kojic acid results in decreased expression of CNKSR2 mRNA
CTD
PMID:16595896
NCBI chr X:156,604,426...156,827,454
Ensembl chr X:156,604,432...156,826,290
G
Col17a1
collagen, type XVII, alpha 1
decreases expression
ISO
kojic acid results in decreased expression of COL17A1 mRNA
CTD
PMID:16595896
NCBI chr19:47,634,783...47,680,460
Ensembl chr19:47,634,783...47,680,533
G
Col24a1
collagen, type XXIV, alpha 1
decreases expression
ISO
kojic acid results in decreased expression of COL24A1 mRNA
CTD
PMID:16595896
NCBI chr 3:144,998,233...145,257,768
Ensembl chr 3:144,998,233...145,257,766
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
increases expression
ISO
kojic acid results in increased expression of COLQ mRNA
CTD
PMID:16595896
NCBI chr14:31,245,039...31,299,820
Ensembl chr14:31,245,039...31,313,300
G
Comt
catechol-O-methyltransferase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA
CTD
PMID:18544905
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Cops2
COP9 signalosome subunit 2
decreases expression
ISO
kojic acid results in decreased expression of COPS2 mRNA
CTD
PMID:16595896
NCBI chr 2:125,672,222...125,701,002
Ensembl chr 2:125,672,224...125,701,059
G
Coq10a
coenzyme Q10A
increases expression
ISO
kojic acid results in increased expression of COQ10A mRNA
CTD
PMID:16595896
NCBI chr10:128,198,965...128,204,849
Ensembl chr10:128,198,969...128,204,866
G
Coq8a
coenzyme Q8A
increases expression
ISO
kojic acid results in increased expression of COQ8A mRNA
CTD
PMID:16595896
NCBI chr 1:179,992,803...180,023,585
Ensembl chr 1:179,992,803...180,027,167
G
Cpb1
carboxypeptidase B1
decreases expression
ISO
kojic acid results in decreased expression of CPB1 mRNA
CTD
PMID:16595896
NCBI chr 3:20,303,643...20,339,681
Ensembl chr 3:20,302,428...20,329,897
G
Cpe
carboxypeptidase E
increases expression
ISO
kojic acid results in increased expression of CPE mRNA
CTD
PMID:16595896
NCBI chr 8:65,045,576...65,146,143
Ensembl chr 8:65,045,576...65,146,088
G
Cpne5
copine V
increases expression
ISO
kojic acid results in increased expression of CPNE5 mRNA
CTD
PMID:16595896
NCBI chr17:29,375,495...29,456,764
Ensembl chr17:29,374,530...29,457,141
G
Creb1
cAMP responsive element binding protein 1
decreases phosphorylation
EXP
kojic acid results in decreased phosphorylation of CREB1 protein
CTD
PMID:27586645
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Cse1l
chromosome segregation 1 like
decreases expression
ISO
kojic acid results in decreased expression of CSE1L mRNA
CTD
PMID:16595896
NCBI chr 2:166,747,961...166,788,309
Ensembl chr 2:166,747,960...166,788,309
G
Ctnnal1
catenin alpha like 1
decreases expression
ISO
kojic acid results in decreased expression of CTNNAL1 mRNA
CTD
PMID:16595896
NCBI chr 4:56,810,935...56,865,370
Ensembl chr 4:56,810,935...56,865,188
G
Ctsz
cathepsin Z
increases expression
ISO
kojic acid results in increased expression of CTSZ mRNA
CTD
PMID:16595896
NCBI chr 2:174,269,287...174,280,832
Ensembl chr 2:174,269,286...174,280,832
G
Cyb5r3
cytochrome b5 reductase 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYB5R3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYB5R3 mRNA
CTD
PMID:18544905
NCBI chr15:83,037,696...83,060,641
Ensembl chr15:83,037,695...83,056,793
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
increases expression
ISO
kojic acid results in increased expression of CYP26B1 mRNA
CTD
PMID:16595896
NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2A5 mRNA
CTD
PMID:17917374
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA
CTD
PMID:17917374
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2b9
cytochrome P450, family 2, subfamily b, polypeptide 9
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA
CTD
PMID:17917374
NCBI chr 7:25,872,775...25,910,086
Ensembl chr 7:25,872,836...25,910,086
G
Cyp2c52-ps
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA
CTD
PMID:18544905
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2D22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2D22 mRNA
CTD
PMID:18544905
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA
CTD
PMID:18544905
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp2f2
cytochrome P450, family 2, subfamily f, polypeptide 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2F2 mRNA
CTD
PMID:18544905
NCBI chr 7:26,819,380...26,833,085
Ensembl chr 7:26,819,334...26,833,085
G
Cyp4a10
cytochrome P450, family 4, subfamily a, polypeptide 10
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP4A10 mRNA
CTD
PMID:17917374
NCBI chr 4:115,375,484...115,390,846
Ensembl chr 4:115,375,461...115,390,846
G
Cyp4a12b
cytochrome P450, family 4, subfamily a, polypeptide 12B
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA
CTD
PMID:18544905
NCBI chr 4:115,268,821...115,296,231
Ensembl chr 4:115,268,821...115,296,231
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA
CTD
PMID:17917374
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Cyp8b1
cytochrome P450, family 8, subfamily b, polypeptide 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP8B1 mRNA
CTD
PMID:18544905
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
G
Cyth3
cytohesin 3
increases expression
ISO
kojic acid results in increased expression of CYTH3 mRNA
CTD
PMID:16595896
NCBI chr 5:143,608,202...143,696,005
Ensembl chr 5:143,608,202...143,696,005
G
Cytip
cytohesin 1 interacting protein
increases expression
ISO
kojic acid results in increased expression of CYTIP mRNA
CTD
PMID:16595896
NCBI chr 2:58,019,151...58,085,559
Ensembl chr 2:58,019,149...58,085,544
G
D6Wsu163e
DNA segment, Chr 6, Wayne State University 163, expressed
decreases expression
ISO
kojic acid results in decreased expression of FERRY3 mRNA
CTD
PMID:16595896
NCBI chr 6:126,916,938...126,952,667
Ensembl chr 6:126,916,925...126,952,930
G
Dagla
diacylglycerol lipase, alpha
increases expression
ISO
kojic acid results in increased expression of DAGLA mRNA
CTD
PMID:16595896
NCBI chr19:10,222,629...10,282,323
Ensembl chr19:10,222,629...10,282,241
G
Dazap2
DAZ associated protein 2
increases expression
ISO
kojic acid results in increased expression of DAZAP2 mRNA
CTD
PMID:16595896
NCBI chr15:100,513,543...100,518,642
Ensembl chr15:100,513,230...100,518,642
G
Dcaf13
DDB1 and CUL4 associated factor 13
decreases expression
ISO
kojic acid results in decreased expression of DCAF13 mRNA
CTD
PMID:16595896
NCBI chr15:38,976,300...39,010,251
Ensembl chr15:38,976,260...39,010,251
G
Dct
dopachrome tautomerase
decreases expression
EXP
kojic acid results in decreased expression of DCT protein
CTD
PMID:27586645
NCBI chr14:118,250,202...118,289,658
Ensembl chr14:118,250,202...118,289,656
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DDIT3 mRNA
CTD
PMID:18544905
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Dek
DEK proto-oncogene
decreases expression
ISO
kojic acid results in decreased expression of DEK mRNA
CTD
PMID:16595896
NCBI chr13:47,238,243...47,261,134
Ensembl chr13:47,238,251...47,259,677
G
Dlgap4
DLG associated protein 4
increases expression
ISO
kojic acid results in increased expression of DLGAP4 mRNA
CTD
PMID:16595896
NCBI chr 2:156,455,431...156,606,283
Ensembl chr 2:156,455,625...156,606,283
G
Dlx1
distal-less homeobox 1
decreases expression
ISO
kojic acid results in decreased expression of DLX1 mRNA
CTD
PMID:16595896
NCBI chr 2:71,358,457...71,364,325
Ensembl chr 2:71,358,457...71,364,325
G
Dmxl1
Dmx-like 1
decreases expression
ISO
kojic acid results in decreased expression of DMXL1 mRNA
CTD
PMID:16595896
NCBI chr18:49,965,657...50,098,540
Ensembl chr18:49,965,737...50,098,540
G
Dnaja1
DnaJ heat shock protein family (Hsp40) member A1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA1 mRNA
CTD
PMID:18544905
NCBI chr 4:40,722,468...40,734,965
Ensembl chr 4:40,722,150...40,737,149
G
Dnaja2
DnaJ heat shock protein family (Hsp40) member A2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DNAJA2 mRNA
CTD
PMID:18544905
NCBI chr 8:86,264,262...86,281,990
Ensembl chr 8:86,264,262...86,281,973
G
Dnttip2
deoxynucleotidyltransferase, terminal, interacting protein 2
decreases expression
ISO
kojic acid results in decreased expression of DNTTIP2 mRNA
CTD
PMID:16595896
NCBI chr 3:122,068,045...122,078,920
Ensembl chr 3:122,068,037...122,078,920
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
kojic acid results in increased expression of DOCK4 mRNA
CTD
PMID:16595896
NCBI chr12:40,495,956...40,896,873
Ensembl chr12:40,495,951...40,896,873
G
Dok4
docking protein 4
decreases expression
ISO
kojic acid results in decreased expression of DOK4 mRNA
CTD
PMID:16595896
NCBI chr 8:95,590,456...95,602,940
Ensembl chr 8:95,590,456...95,602,958
G
Dpyd
dihydropyrimidine dehydrogenase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA
CTD
PMID:18544905
NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
G
Dspp
dentin sialophosphoprotein
decreases expression
ISO
kojic acid results in decreased expression of DSPP mRNA
CTD
PMID:16595896
NCBI chr 5:104,318,569...104,327,993
Ensembl chr 5:104,318,578...104,327,993
G
Dstn
destrin
increases expression
ISO
kojic acid results in increased expression of DSTN mRNA
CTD
PMID:16595896
NCBI chr 2:143,757,251...143,785,244
Ensembl chr 2:143,757,240...143,785,244
G
Dynlt3
dynein light chain Tctex-type 3
decreases expression
ISO
kojic acid results in decreased expression of DYNLT3 mRNA
CTD
PMID:16595896
NCBI chr X:9,520,509...9,529,222
Ensembl chr X:9,520,506...9,529,242
G
E2f3
E2F transcription factor 3
increases expression
ISO
kojic acid results in increased expression of E2F3 mRNA
CTD
PMID:16595896
NCBI chr13:30,090,558...30,171,172
Ensembl chr13:30,090,558...30,170,046
G
E2f8
E2F transcription factor 8
increases expression
ISO
kojic acid results in increased expression of E2F8 mRNA
CTD
PMID:16595896
NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344
G
Efna3
ephrin A3
decreases expression
ISO
kojic acid results in decreased expression of EFNA3 mRNA
CTD
PMID:16595896
NCBI chr 3:89,221,200...89,231,359
Ensembl chr 3:89,221,206...89,230,272
G
Egr1
early growth response 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA
CTD
PMID:18544905
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Eif4e
eukaryotic translation initiation factor 4E
decreases expression
ISO
kojic acid results in decreased expression of EIF4E mRNA
CTD
PMID:16595896
NCBI chr 3:138,231,952...138,265,457
Ensembl chr 3:138,231,940...138,265,457
G
Eif5a2
eukaryotic translation initiation factor 5A2
increases expression
ISO
kojic acid results in increased expression of EIF5A2 mRNA
CTD
PMID:16595896
NCBI chr 3:28,835,426...28,852,995
Ensembl chr 3:28,835,425...28,852,995
G
Elane
elastase, neutrophil expressed
decreases expression
ISO
kojic acid results in decreased expression of ELANE mRNA
CTD
PMID:16595896
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Ep300
E1A binding protein p300
increases expression
ISO
kojic acid results in increased expression of EP300 mRNA
CTD
PMID:16595896
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Epha10
Eph receptor A10
decreases expression
ISO
kojic acid results in decreased expression of EPHA10 mRNA
CTD
PMID:16595896
NCBI chr 4:124,775,408...124,811,594
Ensembl chr 4:124,774,692...124,811,593
G
Epha4
Eph receptor A4
increases expression
ISO
kojic acid results in increased expression of EPHA4 mRNA
CTD
PMID:16595896
NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725
G
Ephx1
epoxide hydrolase 1, microsomal
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA
CTD
PMID:18544905
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Ephx2
epoxide hydrolase 2, cytoplasmic
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA
CTD
PMID:18544905
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Ercc2
excision repair cross-complementing rodent repair deficiency, complementation group 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC2 mRNA
CTD
PMID:17917374
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
G
Ercc3
excision repair cross-complementing rodent repair deficiency, complementation group 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ERCC3 mRNA
CTD
PMID:18544905
NCBI chr18:32,373,357...32,403,206
Ensembl chr18:32,373,353...32,403,204
G
Ercc4
excision repair cross-complementing rodent repair deficiency, complementation group 4
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA
CTD
PMID:17917374
NCBI chr16:12,927,600...12,969,873
Ensembl chr16:12,927,548...12,968,481
G
Ercc5
excision repair cross-complementing rodent repair deficiency, complementation group 5
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA
CTD
PMID:17917374
NCBI chr 1:44,184,084...44,220,399
Ensembl chr 1:44,186,904...44,220,420
G
Esam
endothelial cell-specific adhesion molecule
increases expression
ISO
kojic acid results in increased expression of ESAM mRNA
CTD
PMID:16595896
NCBI chr 9:37,439,385...37,449,615
Ensembl chr 9:37,439,374...37,449,615
G
Esrp1
epithelial splicing regulatory protein 1
increases expression
ISO
kojic acid results in increased expression of ESRP1 mRNA
CTD
PMID:16595896
NCBI chr 4:11,331,933...11,386,783
Ensembl chr 4:11,331,933...11,386,783
G
Exd1
exonuclease 3'-5' domain containing 1
decreases expression
ISO
kojic acid results in decreased expression of EXD1 mRNA
CTD
PMID:16595896
NCBI chr 2:119,346,986...119,378,108
Ensembl chr 2:119,346,986...119,378,108
G
Exoc2
exocyst complex component 2
increases expression
ISO
kojic acid results in increased expression of EXOC2 mRNA
CTD
PMID:16595896
NCBI chr13:30,968,421...31,162,082
Ensembl chr13:30,968,416...30,979,209 Ensembl chr13:30,968,416...30,979,209
G
F10
coagulation factor X
increases expression
ISO
kojic acid results in increased expression of F10 mRNA
CTD
PMID:16595896
NCBI chr 8:13,087,308...13,106,676
Ensembl chr 8:13,087,308...13,106,676
G
Fam241a
family with sequence similarity 241, member A
increases expression
ISO
kojic acid results in increased expression of FAM241A mRNA
CTD
PMID:16595896
NCBI chr 3:127,663,337...127,689,972
Ensembl chr 3:127,662,707...127,689,973
G
Fbn2
fibrillin 2
increases expression
ISO
kojic acid results in increased expression of FBN2 mRNA
CTD
PMID:16595896
NCBI chr18:58,141,689...58,343,200
Ensembl chr18:58,141,695...58,343,559
G
Fbxo16
F-box protein 16
increases expression
ISO
kojic acid results in increased expression of FBXO16 mRNA
CTD
PMID:16595896
NCBI chr14:65,504,067...65,561,422
Ensembl chr14:65,504,067...65,561,422
G
Fgf12
fibroblast growth factor 12
increases expression
ISO
kojic acid results in increased expression of FGF12 mRNA
CTD
PMID:16595896
NCBI chr16:27,976,535...28,571,995
Ensembl chr16:27,978,850...28,571,820
G
Fgf5
fibroblast growth factor 5
decreases expression
ISO
kojic acid results in decreased expression of FGF5 mRNA
CTD
PMID:16595896
NCBI chr 5:98,402,108...98,424,892
Ensembl chr 5:98,402,043...98,424,889
G
Fgfr3
fibroblast growth factor receptor 3
decreases expression
ISO
kojic acid results in decreased expression of FGFR3 mRNA
CTD
PMID:16595896
NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412
G
Fibcd1
fibrinogen C domain containing 1
decreases expression
ISO
kojic acid results in decreased expression of FIBCD1 mRNA
CTD
PMID:16595896
NCBI chr 2:31,703,302...31,736,976
Ensembl chr 2:31,703,302...31,736,017
G
Fkbp10
FK506 binding protein 10
increases expression
ISO
kojic acid results in increased expression of FKBP10 mRNA
CTD
PMID:16595896
NCBI chr11:100,306,520...100,315,666
Ensembl chr11:100,306,523...100,315,650
G
Fmo1
flavin containing monooxygenase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA
CTD
PMID:18544905
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
G
Fpgt
fucose-1-phosphate guanylyltransferase
decreases expression
ISO
kojic acid results in decreased expression of FPGT mRNA
CTD
PMID:16595896
NCBI chr 3:154,790,552...154,799,024
Ensembl chr 3:154,790,555...154,799,040
G
Frmpd4
FERM and PDZ domain containing 4
decreases expression
ISO
kojic acid results in decreased expression of FRMPD4 mRNA
CTD
PMID:16595896
NCBI chr X:166,254,297...167,360,230
Ensembl chr X:166,254,305...167,360,227
G
Fth1
ferritin heavy polypeptide 1
increases expression
ISO
kojic acid results in increased expression of FTH1 mRNA; kojic acid results in increased expression of FTH1 protein
CTD
PMID:23738040
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
G
Fzd8
frizzled class receptor 8
increases expression
ISO
kojic acid results in increased expression of FZD8 mRNA
CTD
PMID:16595896
NCBI chr18:9,212,856...9,216,201
Ensembl chr18:9,212,163...9,218,136
G
Gadd45b
growth arrest and DNA-damage-inducible 45 beta
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GADD45B mRNA
CTD
PMID:18544905
NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
decreases expression
ISO
kojic acid results in decreased expression of GALNT1 mRNA
CTD
PMID:16595896
NCBI chr18:24,338,401...24,419,873
Ensembl chr18:24,338,401...24,419,875
G
Gfod1
glucose-fructose oxidoreductase domain containing 1
decreases expression
ISO
kojic acid results in decreased expression of GFOD1 mRNA
CTD
PMID:16595896
NCBI chr13:43,348,716...43,457,648
Ensembl chr13:43,348,721...43,457,648
G
Gle1
GLE1 RNA export mediator
decreases expression
ISO
kojic acid results in decreased expression of GLE1 mRNA
CTD
PMID:16595896
NCBI chr 2:29,825,421...29,849,444
Ensembl chr 2:29,825,438...29,850,383
G
Gm12695
predicted gene 12695
decreases expression
ISO
kojic acid results in decreased expression of C1ORF87 mRNA
CTD
PMID:16595896
NCBI chr 4:96,611,818...96,675,067
Ensembl chr 4:96,611,884...96,673,423
G
Gmpr
guanosine monophosphate reductase
decreases expression
ISO
kojic acid results in decreased expression of GMPR mRNA
CTD
PMID:16595896
NCBI chr13:45,660,905...45,699,862
Ensembl chr13:45,660,920...45,707,276
G
Gnb1
guanine nucleotide binding protein (G protein), beta 1
increases expression
ISO
kojic acid results in increased expression of GNB1 mRNA
CTD
PMID:16595896
NCBI chr 4:155,575,514...155,643,726
Ensembl chr 4:155,575,818...155,643,726
G
Gpr146
G protein-coupled receptor 146
decreases expression
ISO
kojic acid results in decreased expression of GPR146 mRNA
CTD
PMID:16595896
NCBI chr 5:139,363,452...139,382,170
Ensembl chr 5:139,363,452...139,382,170
G
Gpr26
G protein-coupled receptor 26
decreases expression
ISO
kojic acid results in decreased expression of GPR26 mRNA
CTD
PMID:16595896
NCBI chr 7:131,567,891...131,587,362
Ensembl chr 7:131,568,189...131,596,134
G
Gpr61
G protein-coupled receptor 61
decreases expression
ISO
kojic acid results in decreased expression of GPR61 mRNA
CTD
PMID:16595896
NCBI chr 3:108,055,660...108,062,218
Ensembl chr 3:108,055,637...108,062,198
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GPX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GPX1 mRNA
CTD
PMID:18544905
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gsdma
gasdermin A
decreases expression
ISO
kojic acid results in decreased expression of GSDMA mRNA
CTD
PMID:16595896
NCBI chr11:98,555,163...98,568,534
Ensembl chr11:98,555,177...98,568,534
G
Gsr
glutathione reductase
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of GSR mRNA
CTD
PMID:17917374
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gsta2
glutathione S-transferase, alpha 2 (Yc2)
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA2 mRNA
CTD
PMID:18544905
NCBI chr 9:78,238,300...78,254,474
Ensembl chr 9:78,238,300...78,263,070
G
Gsta4
glutathione S-transferase, alpha 4
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA
CTD
PMID:18544905
NCBI chr 9:78,099,248...78,116,631
Ensembl chr 9:78,090,056...78,116,631
G
Gstm1
glutathione S-transferase, mu 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM1 mRNA
CTD
PMID:18544905
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstm2
glutathione S-transferase, mu 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM2 mRNA
CTD
PMID:18544905
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
G
Gstm5
glutathione S-transferase, mu 5
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
G
Gucy1a2
guanylate cyclase 1, soluble, alpha 2
decreases expression
ISO
kojic acid results in decreased expression of GUCY1A2 mRNA
CTD
PMID:16595896
NCBI chr 9:3,532,349...3,905,791
Ensembl chr 9:3,532,778...3,894,736
G
H1f1
H1.1 linker histone, cluster member
increases expression
ISO
kojic acid results in increased expression of H1-1 mRNA
CTD
PMID:16595896
NCBI chr13:23,947,651...23,948,395
Ensembl chr13:23,947,649...23,948,389
G
H2ac10
H2A clustered histone 10
increases expression
ISO
kojic acid results in increased expression of H2AC14 mRNA
CTD
PMID:16595896
NCBI chr13:23,718,045...23,718,548
Ensembl chr13:23,718,076...23,718,474
G
Hand1
heart and neural crest derivatives expressed 1
increases expression
ISO
kojic acid results in increased expression of HAND1 mRNA
CTD
PMID:16595896
NCBI chr11:57,719,539...57,722,973
Ensembl chr11:57,719,531...57,723,644
G
Harbi1
harbinger transposase derived 1
decreases expression
ISO
kojic acid results in decreased expression of HARBI1 mRNA
CTD
PMID:16595896
NCBI chr 2:91,541,197...91,554,016
Ensembl chr 2:91,541,197...91,551,890
G
Hibch
3-hydroxyisobutyryl-Coenzyme A hydrolase
decreases expression
ISO
kojic acid results in decreased expression of HIBCH mRNA
CTD
PMID:16595896
NCBI chr 1:52,884,197...52,960,145
Ensembl chr 1:52,884,088...52,960,145
G
Hint3
histidine triad nucleotide binding protein 3
increases expression
ISO
kojic acid results in increased expression of HINT3 mRNA
CTD
PMID:16595896
NCBI chr10:30,479,191...30,499,526
Ensembl chr10:30,484,137...30,505,628
G
Hip1
huntingtin interacting protein 1
increases expression
ISO
kojic acid results in increased expression of HIP1 mRNA
CTD
PMID:16595896
NCBI chr 5:135,435,350...135,574,167
Ensembl chr 5:135,435,385...135,573,974
G
Hlf
hepatic leukemia factor
decreases expression
ISO
kojic acid results in decreased expression of HLF mRNA
CTD
PMID:16595896
NCBI chr11:90,227,361...90,281,745
Ensembl chr11:90,227,362...90,281,721
G
Hmmr
hyaluronan mediated motility receptor (RHAMM)
decreases expression
ISO
kojic acid results in decreased expression of HMMR mRNA
CTD
PMID:16595896
NCBI chr11:40,592,215...40,624,290
Ensembl chr11:40,592,222...40,624,249
G
Hmox2
heme oxygenase 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HMOX2 mRNA
CTD
PMID:18544905
NCBI chr16:4,544,225...4,584,606
Ensembl chr16:4,544,225...4,584,606
G
Hnrnph2
heterogeneous nuclear ribonucleoprotein H2
increases expression
ISO
kojic acid results in increased expression of HNRNPH2 mRNA
CTD
PMID:16595896
NCBI chr X:133,501,928...133,507,809
Ensembl chr X:133,501,928...133,507,809
G
Hps3
HPS3, biogenesis of lysosomal organelles complex 2 subunit 1
decreases expression
ISO
kojic acid results in decreased expression of HPS3 mRNA
CTD
PMID:16595896
NCBI chr 3:20,050,109...20,089,478
Ensembl chr 3:20,050,109...20,089,479
G
Hsp90aa1
heat shock protein 90, alpha (cytosolic), class A member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AA1 mRNA
CTD
PMID:18544905
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
G
Hsp90ab1
heat shock protein 90 alpha (cytosolic), class B member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSP90AB1 mRNA
CTD
PMID:18544905
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
G
Hspa1a
heat shock protein 1A
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA1A mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSPA1A mRNA
CTD
PMID:18544905
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa5
heat shock protein 5
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA
CTD
PMID:18544905
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspb1
heat shock protein 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPB1 mRNA
CTD
PMID:18544905
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Hspd1
heat shock protein 1 (chaperonin)
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPD1 mRNA
CTD
PMID:18544905
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Hspe1
heat shock protein 1 (chaperonin 10)
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of HSPE1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPE1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 1:55,127,307...55,130,476
Ensembl chr 1:55,127,291...55,130,466
G
Hyou1
hypoxia up-regulated 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HYOU1 mRNA
CTD
PMID:18544905
NCBI chr 9:44,290,840...44,303,662
Ensembl chr 9:44,290,787...44,303,666
G
Igf2r
insulin-like growth factor 2 receptor
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of IGF2R mRNA
CTD
PMID:18544905
NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1A mRNA
CTD
PMID:18544905
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1B mRNA
CTD
PMID:18544905
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
increases expression
EXP
kojic acid results in increased expression of IL1RL1 mRNA
CTD
PMID:19000923
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il22ra1
interleukin 22 receptor, alpha 1
increases expression
ISO
kojic acid results in increased expression of IL22RA1 mRNA
CTD
PMID:16595896
NCBI chr 4:135,455,470...135,482,694
Ensembl chr 4:135,455,483...135,479,451
G
Il6
interleukin 6
decreases expression
ISO
kojic acid results in decreased expression of IL6 protein
CTD
PMID:12727023
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il6st
interleukin 6 signal transducer
decreases expression
ISO
kojic acid results in decreased expression of IL6ST mRNA
CTD
PMID:16595896
NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
G
Incenp
inner centromere protein
increases expression
ISO
kojic acid results in increased expression of INCENP mRNA
CTD
PMID:16595896
NCBI chr19:9,849,659...9,876,853
Ensembl chr19:9,849,660...9,876,915
G
Jun
jun proto-oncogene
increases expression
EXP
kojic acid results in increased expression of JUN mRNA
CTD
PMID:19000923
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kars1
lysyl-tRNA synthetase 1
decreases expression
ISO
kojic acid results in decreased expression of KARS1 mRNA
CTD
PMID:16595896
NCBI chr 8:112,720,071...112,737,986
Ensembl chr 8:112,720,075...112,737,955
G
Kcnab3
potassium voltage-gated channel, shaker-related subfamily, beta member 3
decreases expression
ISO
kojic acid results in decreased expression of KCNAB3 mRNA
CTD
PMID:16595896
NCBI chr11:69,217,084...69,223,867
Ensembl chr11:69,217,084...69,223,868
G
Kctd17
potassium channel tetramerisation domain containing 17
decreases expression
ISO
kojic acid results in decreased expression of KCTD17 mRNA
CTD
PMID:16595896
NCBI chr15:78,312,578...78,323,503
Ensembl chr15:78,312,764...78,323,503
G
Kdm4d
lysine (K)-specific demethylase 4D
increases expression
ISO
kojic acid results in increased expression of KDM4D mRNA
CTD
PMID:16595896
NCBI chr 9:14,373,844...14,411,818
Ensembl chr 9:14,373,844...14,411,778
G
Klf5
Kruppel-like transcription factor 5
increases expression
ISO
kojic acid results in increased expression of KLF5 mRNA
CTD
PMID:16595896
NCBI chr14:99,536,127...99,550,848
Ensembl chr14:99,536,127...99,552,472
G
Klhl13
kelch-like 13
increases expression
ISO
kojic acid results in increased expression of KLHL13 mRNA
CTD
PMID:16595896
NCBI chr X:23,085,510...23,231,340
Ensembl chr X:23,085,510...23,231,321
G
Klkb1
kallikrein B, plasma 1
decreases expression
ISO
kojic acid results in decreased expression of KLKB1 mRNA
CTD
PMID:16595896
NCBI chr 8:45,719,725...45,747,872
Ensembl chr 8:45,719,726...45,747,896
G
Krt7
keratin 7
increases expression
ISO
kojic acid results in increased expression of KRT7 mRNA
CTD
PMID:16595896
NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
G
Ktn1
kinectin 1
decreases expression
ISO
kojic acid results in decreased expression of KTN1 mRNA
CTD
PMID:16595896
NCBI chr14:47,886,551...47,974,021
Ensembl chr14:47,885,905...47,977,351
G
Larp7
La ribonucleoprotein 7, transcriptional regulator
decreases expression
ISO
kojic acid results in decreased expression of LARP7 mRNA
CTD
PMID:16595896
NCBI chr 3:127,330,363...127,346,998
Ensembl chr 3:127,330,363...127,346,998
G
Lrp6
low density lipoprotein receptor-related protein 6
decreases expression
ISO
kojic acid results in decreased expression of LRP6 mRNA
CTD
PMID:16595896
NCBI chr 6:134,423,439...134,543,876
Ensembl chr 6:134,423,439...134,543,928
G
Lrrc4
leucine rich repeat containing 4
decreases expression
ISO
kojic acid results in decreased expression of LRRC4 mRNA
CTD
PMID:16595896
NCBI chr 6:28,828,125...28,831,746
Ensembl chr 6:28,661,830...28,831,746
G
Lrrc9
leucine rich repeat containing 9
increases expression
ISO
kojic acid results in increased expression of LRRC9 mRNA
CTD
PMID:16595896
NCBI chr12:72,481,391...72,561,269
Ensembl chr12:72,488,640...72,577,524
G
Maea
macrophage erythroblast attacher
increases expression
ISO
kojic acid results in increased expression of MAEA mRNA
CTD
PMID:16595896
NCBI chr 5:33,492,916...33,530,638
Ensembl chr 5:33,492,853...33,530,640
G
Mafk
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian)
decreases expression
ISO
kojic acid results in decreased expression of MAFK mRNA
CTD
PMID:16595896
NCBI chr 5:139,777,291...139,788,409
Ensembl chr 5:139,777,268...139,788,408
G
Magec2
MAGE family member C2
increases expression
ISO
kojic acid results in increased expression of MAGEC2 mRNA
CTD
PMID:16595896
NCBI chr X:61,326,566...61,335,690
Ensembl chr X:61,327,105...61,335,684
G
Magef1
MAGE family member F1
increases expression
ISO
kojic acid results in increased expression of MAGEF1 mRNA
CTD
PMID:16595896
NCBI chr16:21,150,650...21,152,106
Ensembl chr16:21,151,396...21,151,879 Ensembl chr16:21,151,396...21,151,879
G
Maoa
monoamine oxidase A
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOA mRNA
CTD
PMID:18544905
NCBI chr X:16,485,937...16,554,051
Ensembl chr X:16,485,937...16,554,057
G
Maob
monoamine oxidase B
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MAOB mRNA
CTD
PMID:18544905
NCBI chr X:16,575,520...16,683,605
Ensembl chr X:16,575,521...16,683,605
G
Map7d2
MAP7 domain containing 2
decreases expression
ISO
kojic acid results in decreased expression of MAP7D2 mRNA
CTD
PMID:16595896
NCBI chr X:158,197,488...158,281,954
Ensembl chr X:158,197,568...158,281,753
G
Mapk1
mitogen-activated protein kinase 1
decreases phosphorylation
EXP
kojic acid results in decreased phosphorylation of MAPK1 protein
CTD
PMID:27586645
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
decreases phosphorylation
EXP
kojic acid results in decreased phosphorylation of MAPK3 protein
CTD
PMID:27586645
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
decreases expression
ISO
kojic acid results in decreased expression of MAPK8 mRNA
CTD
PMID:16595896
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mbnl1
muscleblind like splicing regulator 1
decreases expression
ISO
kojic acid results in decreased expression of MBNL1 mRNA
CTD
PMID:16595896
NCBI chr 3:60,380,209...60,537,171
Ensembl chr 3:60,380,251...60,537,171
G
Mc1r
melanocortin 1 receptor
decreases expression increases expression
EXP ISO
kojic acid results in decreased expression of MC1R protein kojic acid results in increased expression of MC1R protein
CTD
PMID:23738040 PMID:27586645
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
G
Mdfi
MyoD family inhibitor
decreases expression
ISO
kojic acid results in decreased expression of MDFI mRNA
CTD
PMID:16595896
NCBI chr17:48,126,253...48,145,616
Ensembl chr17:48,126,253...48,145,616
G
Mdm2
transformed mouse 3T3 cell double minute 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA
CTD
PMID:18544905
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Me3
malic enzyme 3, NADP(+)-dependent, mitochondrial
decreases expression
ISO
kojic acid results in decreased expression of ME3 mRNA
CTD
PMID:16595896
NCBI chr 7:89,281,492...89,503,423
Ensembl chr 7:89,281,600...89,503,567
G
Med14
mediator complex subunit 14
increases expression
ISO
kojic acid results in increased expression of MED14 mRNA
CTD
PMID:16595896
NCBI chr X:12,541,607...12,628,813
Ensembl chr X:12,541,608...12,628,312
G
Mex3b
mex3 RNA binding family member B
increases expression
ISO
kojic acid results in increased expression of MEX3B mRNA
CTD
PMID:16595896
NCBI chr 7:82,516,541...82,520,784
Ensembl chr 7:82,516,541...82,520,723
G
Mfap4
microfibrillar-associated protein 4
decreases expression
ISO
kojic acid results in decreased expression of MFAP4 mRNA
CTD
PMID:16595896
NCBI chr11:61,376,257...61,379,536
Ensembl chr11:61,376,257...61,379,726
G
Mgmt
O-6-methylguanine-DNA methyltransferase
multiple interactions
ISO
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA]
CTD
PMID:18544905
NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
G
Mgst1
microsomal glutathione S-transferase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MGST1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MGST1 mRNA
CTD
PMID:18544905
NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753
G
Midn
midnolin
decreases expression
ISO
kojic acid results in decreased expression of MIDN mRNA
CTD
PMID:16595896
NCBI chr10:79,984,106...79,994,202
Ensembl chr10:79,984,106...79,994,202
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MIF mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MIF mRNA
CTD
PMID:18544905
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mnd1
meiotic nuclear divisions 1
increases expression
ISO
kojic acid results in increased expression of GAJ mRNA
CTD
PMID:16595896
NCBI chr 3:83,995,240...84,063,084
Ensembl chr 3:83,995,240...84,063,093
G
Mrpl30
mitochondrial ribosomal protein L30
decreases expression
ISO
kojic acid results in decreased expression of MRPL30 mRNA
CTD
PMID:16595896
NCBI chr 1:37,929,558...37,937,419
Ensembl chr 1:37,929,558...37,937,616
G
mt-Co1
cytochrome c oxidase I, mitochondrial
increases expression
ISO
kojic acid results in increased expression of COX1 mRNA; kojic acid results in increased expression of COX1 protein
CTD
PMID:23738040
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
G
Mtrex
Mtr4 exosome RNA helicase
decreases expression
ISO
kojic acid results in decreased expression of MTREX mRNA
CTD
PMID:16595896
NCBI chr13:113,004,306...113,063,914
Ensembl chr13:113,003,952...113,063,932
G
Mvp
major vault protein
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MVP mRNA
CTD
PMID:18544905
NCBI chr 7:126,586,036...126,613,729
Ensembl chr 7:126,586,032...126,613,793
G
Naa25
N(alpha)-acetyltransferase 25, NatB auxiliary subunit
increases expression
ISO
kojic acid results in increased expression of NAA25 mRNA
CTD
PMID:16595896
NCBI chr 5:121,535,977...121,580,612
Ensembl chr 5:121,535,999...121,582,441
G
Ncald
neurocalcin delta
decreases expression
ISO
kojic acid results in decreased expression of NCALD mRNA
CTD
PMID:16595896
NCBI chr15:37,366,419...37,792,816
Ensembl chr15:37,366,419...37,792,814
G
Ndufa1
NADH:ubiquinone oxidoreductase subunit A1
increases expression
ISO
kojic acid results in increased expression of NDUFA1 mRNA
CTD
PMID:16595896
NCBI chr X:36,451,241...36,454,891
Ensembl chr X:36,451,241...36,454,816
G
Nectin4
nectin cell adhesion molecule 4
increases expression
ISO
kojic acid results in increased expression of NECTIN4 mRNA
CTD
PMID:16595896
NCBI chr 1:171,197,741...171,215,855
Ensembl chr 1:171,197,667...171,216,166
G
Nfil3
nuclear factor, interleukin 3, regulated
increases expression
ISO
kojic acid results in increased expression of NFIL3 mRNA
CTD
PMID:16595896
NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NFKBIA mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NFKBIA mRNA
CTD
PMID:18544905
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nfkbie
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon
increases expression
ISO
kojic acid results in increased expression of NFKBIE mRNA
CTD
PMID:16595896
NCBI chr17:45,866,626...45,874,095
Ensembl chr17:45,866,629...45,874,095
G
Nkx6-1
NK6 homeobox 1
decreases expression
ISO
kojic acid results in decreased expression of NKX6-1 mRNA
CTD
PMID:16595896
NCBI chr 5:101,807,050...101,812,577
Ensembl chr 5:101,806,005...101,812,862
G
Nlgn2
neuroligin 2
decreases expression
ISO
kojic acid results in decreased expression of NLGN2 mRNA
CTD
PMID:16595896
NCBI chr11:69,713,949...69,728,610
Ensembl chr11:69,713,948...69,728,610
G
Noc3l
NOC3 like DNA replication regulator
decreases expression
ISO
kojic acid results in decreased expression of NOC3L mRNA
CTD
PMID:16595896
NCBI chr19:38,776,565...38,808,754
Ensembl chr19:38,776,572...38,807,681
G
Nol11
nucleolar protein 11
decreases expression
ISO
kojic acid results in decreased expression of NOL11 mRNA
CTD
PMID:16595896
NCBI chr11:107,057,477...107,080,207
Ensembl chr11:107,057,489...107,080,207
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I2 mRNA
CTD
PMID:18544905
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NR1I3 mRNA
CTD
PMID:18544905
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Odad2
outer dynein arm docking complex subunit 2
increases expression
ISO
kojic acid results in increased expression of ODAD2 mRNA
CTD
PMID:16595896
NCBI chr18:7,088,233...7,298,272
Ensembl chr18:7,088,209...7,297,936
G
Olfml1
olfactomedin-like 1
decreases expression
ISO
kojic acid results in decreased expression of OLFML1 mRNA
CTD
PMID:16595896
NCBI chr 7:107,166,640...107,190,572
Ensembl chr 7:107,166,653...107,190,301
G
Or51b4
olfactory receptor family 51 subfamily B member 4
decreases expression
ISO
kojic acid results in decreased expression of OR51B4 mRNA
CTD
PMID:16595896
NCBI chr 7:103,530,513...103,531,448
Ensembl chr 7:103,528,650...103,535,459
G
Osbp2
oxysterol binding protein 2
decreases expression
ISO
kojic acid results in decreased expression of OSBP2 mRNA
CTD
PMID:16595896
NCBI chr11:3,653,731...3,814,000
Ensembl chr11:3,653,731...3,813,903
G
Ostm1
osteopetrosis associated transmembrane protein 1
decreases expression
ISO
kojic acid results in decreased expression of OSTM1 mRNA
CTD
PMID:16595896
NCBI chr10:42,554,912...42,578,458
Ensembl chr10:42,459,818...42,578,455
G
Otx1
orthodenticle homeobox 1
increases expression
ISO
kojic acid results in increased expression of OTX1 mRNA
CTD
PMID:16595896
NCBI chr11:21,944,764...21,954,044
Ensembl chr11:21,944,764...21,952,897
G
Pabir1
PP2A A alpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1
increases expression
ISO
kojic acid results in increased expression of PABIR1 mRNA
CTD
PMID:16595896
NCBI chr19:24,451,270...24,454,819
Ensembl chr19:24,453,866...24,454,720
G
Pagr1a
PAXIP1 associated glutamate rich protein 1A
increases expression
ISO
kojic acid results in increased expression of PAGR1 mRNA
CTD
PMID:16595896
NCBI chr 7:126,614,223...126,616,524
Ensembl chr 7:126,614,205...126,616,524 Ensembl chr 7:126,614,205...126,616,524
G
Pah
phenylalanine hydroxylase
decreases expression
ISO
kojic acid results in decreased expression of PAH mRNA
CTD
PMID:16595896
NCBI chr10:87,357,657...87,419,999
Ensembl chr10:87,357,657...87,419,998
G
Parg
poly (ADP-ribose) glycohydrolase
increases expression
ISO
kojic acid results in increased expression of PARG mRNA
CTD
PMID:16595896
NCBI chr14:31,923,900...32,020,671
Ensembl chr14:31,923,906...32,019,507
G
Pbk
PDZ binding kinase
decreases expression
ISO
kojic acid results in decreased expression of PBK mRNA
CTD
PMID:16595896
NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of PCNA protein [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of PCNA protein
CTD
PMID:17917374 PMID:18544905
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pcnx3
pecanex homolog 3
decreases expression
ISO
kojic acid results in decreased expression of PCNX3 mRNA
CTD
PMID:16595896
NCBI chr19:5,714,663...5,739,036
Ensembl chr19:5,714,663...5,738,936
G
Pcsk4
proprotein convertase subtilisin/kexin type 4
decreases expression
ISO
kojic acid results in decreased expression of PCSK4 mRNA
CTD
PMID:16595896
NCBI chr10:80,157,117...80,165,583
Ensembl chr10:80,157,117...80,165,332
G
Pdcl
phosducin-like
increases expression
ISO
kojic acid results in increased expression of PDCL mRNA
CTD
PMID:16595896
NCBI chr 2:37,240,086...37,249,832
Ensembl chr 2:37,240,086...37,249,344
G
Pdha1
pyruvate dehydrogenase E1 alpha 1
increases expression
ISO
kojic acid results in increased expression of PDHA1 mRNA
CTD
PMID:16595896
NCBI chr X:158,905,215...158,921,426
Ensembl chr X:158,905,205...158,921,409
G
Pdia3
protein disulfide isomerase associated 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PDIA3 mRNA
CTD
PMID:18544905
NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168
G
Pdlim2
PDZ and LIM domain 2
increases expression
ISO
kojic acid results in increased expression of PDLIM2 mRNA
CTD
PMID:16595896
NCBI chr14:70,401,667...70,415,140
Ensembl chr14:70,401,667...70,415,130
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
decreases expression
ISO
kojic acid results in decreased expression of PERM1 mRNA
CTD
PMID:16595896
NCBI chr 4:156,287,724...156,305,766
Ensembl chr 4:156,300,325...156,305,764
G
Pex5l
peroxisomal biogenesis factor 5-like
decreases expression
ISO
kojic acid results in decreased expression of PEX5L mRNA
CTD
PMID:16595896
NCBI chr 3:33,002,075...33,197,470
Ensembl chr 3:33,003,557...33,197,396
G
Pgm2
phosphoglucomutase 2
increases expression
ISO
kojic acid results in increased expression of PGM2 mRNA
CTD
PMID:16595896
NCBI chr 5:64,250,258...64,285,698
Ensembl chr 5:64,250,293...64,285,694
G
Pigq
phosphatidylinositol glycan anchor biosynthesis, class Q
decreases expression
ISO
kojic acid results in decreased expression of PIGQ mRNA
CTD
PMID:16595896
NCBI chr17:26,145,398...26,161,855
Ensembl chr17:26,145,395...26,163,910
G
Pitpnb
phosphatidylinositol transfer protein, beta
increases expression
ISO
kojic acid results in increased expression of PITPNB mRNA
CTD
PMID:16595896
NCBI chr 5:111,478,563...111,536,225
Ensembl chr 5:111,478,629...111,536,225
G
Plagl1
pleiomorphic adenoma gene-like 1
increases expression
ISO
kojic acid results in increased expression of PLAGL1 mRNA
CTD
PMID:16595896
NCBI chr10:12,966,576...13,007,438
Ensembl chr10:12,936,248...13,007,438
G
Poglut2
protein O-glucosyltransferase 2
increases expression
ISO
kojic acid results in increased expression of POGLUT2 mRNA
CTD
PMID:16595896
NCBI chr 1:44,143,060...44,158,844
Ensembl chr 1:44,145,706...44,157,968
G
Pon3
paraoxonase 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA
CTD
PMID:18544905
NCBI chr 6:5,216,253...5,256,236
Ensembl chr 6:5,220,852...5,256,286
G
Por
cytochrome p450 oxidoreductase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of POR mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of POR mRNA
CTD
PMID:18544905
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Pou2f3
POU domain, class 2, transcription factor 3
decreases expression
ISO
kojic acid results in decreased expression of POU2F3 mRNA
CTD
PMID:16595896
NCBI chr 9:43,035,222...43,117,052
Ensembl chr 9:43,035,234...43,121,666
G
Ppp4r1
protein phosphatase 4, regulatory subunit 1
increases expression
ISO
kojic acid results in increased expression of PPP4R1 mRNA
CTD
PMID:16595896
NCBI chr17:66,089,253...66,148,921
Ensembl chr17:66,089,568...66,148,921
G
Prdx1
peroxiredoxin 1
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX1 mRNA
CTD
PMID:18544905
NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019
G
Prdx2
peroxiredoxin 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX2 mRNA
CTD
PMID:18544905
NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463
G
Prg2
proteoglycan 2, bone marrow
decreases expression
ISO
kojic acid results in decreased expression of PRG2 mRNA
CTD
PMID:16595896
NCBI chr 2:84,810,805...84,813,977
Ensembl chr 2:84,810,805...84,813,976
G
Prickle3
prickle planar cell polarity protein 3
decreases expression
ISO
kojic acid results in decreased expression of PRICKLE3 mRNA
CTD
PMID:16595896
NCBI chr X:7,523,616...7,535,086
Ensembl chr X:7,523,499...7,534,425
G
Prim1
DNA primase, p49 subunit
decreases expression
ISO
kojic acid results in decreased expression of PRIM1 mRNA
CTD
PMID:16595896
NCBI chr10:127,851,084...127,865,899
Ensembl chr10:127,851,041...127,865,906
G
Prmt2
protein arginine N-methyltransferase 2
decreases expression
ISO
kojic acid results in decreased expression of PRMT2 mRNA
CTD
PMID:16595896
NCBI chr10:76,043,060...76,073,699
Ensembl chr10:76,043,056...76,073,699
G
Prpf40a
pre-mRNA processing factor 40A
decreases expression
ISO
kojic acid results in decreased expression of PRPF40A mRNA
CTD
PMID:16595896
NCBI chr 2:53,024,714...53,081,450
Ensembl chr 2:53,024,716...53,081,714
G
Prps2
phosphoribosyl pyrophosphate synthetase 2
increases expression
ISO
kojic acid results in increased expression of PRPS2 mRNA
CTD
PMID:16595896
NCBI chr X:166,129,316...166,165,887
Ensembl chr X:166,129,318...166,165,745
G
Prr18
proline rich 18
decreases expression
ISO
kojic acid results in decreased expression of PRR18 mRNA
CTD
PMID:16595896
NCBI chr17:8,546,378...8,562,945
Ensembl chr17:8,556,291...8,562,945
G
Prrc2c
proline-rich coiled-coil 2C
increases expression
ISO
kojic acid results in increased expression of PRRC2C mRNA
CTD
PMID:16595896
NCBI chr 1:162,499,354...162,568,125
Ensembl chr 1:162,498,294...162,568,125
G
Prrx1
paired related homeobox 1
decreases expression
ISO
kojic acid results in decreased expression of PRRX1 mRNA
CTD
PMID:16595896
NCBI chr 1:163,072,688...163,142,714
Ensembl chr 1:163,072,688...163,141,279
G
Psmc6
proteasome (prosome, macropain) 26S subunit, ATPase, 6
decreases expression
ISO
kojic acid results in decreased expression of PSMC6 mRNA
CTD
PMID:16595896
NCBI chr14:45,567,285...45,587,150
Ensembl chr14:45,567,245...45,587,162
G
Psmd3
proteasome (prosome, macropain) 26S subunit, non-ATPase, 3
decreases expression
ISO
kojic acid results in decreased expression of PSMD3 mRNA
CTD
PMID:16595896
NCBI chr11:98,573,380...98,586,804
Ensembl chr11:98,573,380...98,586,805
G
Pus7l
pseudouridylate synthase 7-like
decreases expression
ISO
kojic acid results in decreased expression of PUS7L mRNA
CTD
PMID:16595896
NCBI chr15:94,420,521...94,441,397
Ensembl chr15:94,420,569...94,441,428
G
Rab3gap1
RAB3 GTPase activating protein subunit 1
increases expression
ISO
kojic acid results in increased expression of RAB3GAP1 mRNA
CTD
PMID:16595896
NCBI chr 1:127,796,492...127,871,612
Ensembl chr 1:127,796,510...127,871,605
G
Rab6b
RAB6B, member RAS oncogene family
decreases expression
ISO
kojic acid results in decreased expression of RAB6B mRNA
CTD
PMID:16595896
NCBI chr 9:102,988,866...103,062,475
Ensembl chr 9:102,988,986...103,062,475
G
Rad1
RAD1 checkpoint DNA exonuclease
increases expression
ISO
kojic acid results in increased expression of RAD1 mRNA
CTD
PMID:16595896
NCBI chr15:10,486,104...10,499,149
Ensembl chr15:10,486,104...10,499,149
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RAD23A mRNA
CTD
PMID:18544905
NCBI chr 8:85,561,540...85,567,361
Ensembl chr 8:85,560,648...85,567,294
G
Rad50
RAD50 double strand break repair protein
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of RAD50 mRNA
CTD
PMID:17917374
NCBI chr11:53,540,346...53,598,146
Ensembl chr11:53,540,346...53,598,146
G
Rara
retinoic acid receptor, alpha
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA
CTD
PMID:18544905
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
Rarb
retinoic acid receptor, beta
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of RARB mRNA
CTD
PMID:18544905
NCBI chr14:5,387,365...6,038,924
Ensembl chr14:5,650,540...6,038,924
G
Rasd1
RAS, dexamethasone-induced 1
increases expression
ISO
kojic acid results in increased expression of RASD1 mRNA
CTD
PMID:16595896
NCBI chr11:59,854,007...59,855,770
Ensembl chr11:59,854,007...59,855,770
G
Rasgef1b
RasGEF domain family, member 1B
decreases expression
ISO
kojic acid results in decreased expression of RASGEF1B mRNA
CTD
PMID:16595896
NCBI chr 5:99,365,279...99,400,786
Ensembl chr 5:99,365,285...99,876,924
G
Rassf3
Ras association (RalGDS/AF-6) domain family member 3
increases expression
ISO
kojic acid results in increased expression of RASSF3 mRNA
CTD
PMID:16595896
NCBI chr10:121,246,255...121,312,220
Ensembl chr10:121,246,255...121,312,252
G
Rb1cc1
RB1-inducible coiled-coil 1
decreases expression
ISO
kojic acid results in decreased expression of RB1CC1 mRNA
CTD
PMID:16595896
NCBI chr 1:6,284,858...6,346,599
Ensembl chr 1:6,276,421...6,346,872
G
Rbm38
RNA binding motif protein 38
decreases expression
ISO
kojic acid results in decreased expression of RBM38 mRNA
CTD
PMID:16595896
NCBI chr 2:172,863,722...172,876,527
Ensembl chr 2:172,862,291...172,876,527
G
Recql
RecQ protein-like
decreases expression
ISO
kojic acid results in decreased expression of RECQL mRNA
CTD
PMID:16595896
NCBI chr 6:142,296,068...142,332,802
Ensembl chr 6:142,296,068...142,332,813
G
Rims2
regulating synaptic membrane exocytosis 2
decreases expression
ISO
kojic acid results in decreased expression of RIMS2 mRNA
CTD
PMID:16595896
NCBI chr15:39,061,681...39,547,768
Ensembl chr15:39,061,656...39,547,768
G
Rsbn1
rosbin, round spermatid basic protein 1
decreases expression
ISO
kojic acid results in decreased expression of RSBN1 mRNA
CTD
PMID:16595896
NCBI chr 3:103,821,412...103,873,952
Ensembl chr 3:103,821,436...103,873,952
G
Saa4
serum amyloid A 4
decreases expression
ISO
kojic acid results in decreased expression of SAA4 mRNA
CTD
PMID:16595896
NCBI chr 7:46,377,416...46,382,027
Ensembl chr 7:46,377,422...46,382,027
G
Scarb1
scavenger receptor class B, member 1
increases expression
EXP
kojic acid results in increased expression of SCARB1 mRNA
CTD
PMID:19000923
NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158
G
Scn10a
sodium channel, voltage-gated, type X, alpha
decreases expression
ISO
kojic acid results in decreased expression of SCN10A mRNA
CTD
PMID:16595896
NCBI chr 9:119,437,522...119,548,388
Ensembl chr 9:119,437,522...119,548,388
G
Scp2
sterol carrier protein 2, liver
decreases expression
ISO
kojic acid results in decreased expression of SCP2 mRNA
CTD
PMID:16595896
NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
G
Sdc4
syndecan 4
decreases expression
ISO
kojic acid results in decreased expression of SDC4 mRNA
CTD
PMID:16595896
NCBI chr 2:164,266,167...164,285,512
Ensembl chr 2:164,266,167...164,285,807
G
Sec24b
SEC24 homolog B, COPII coat complex component
increases expression
ISO
kojic acid results in increased expression of SEC24B mRNA
CTD
PMID:16595896
NCBI chr 3:129,776,408...129,855,248
Ensembl chr 3:129,776,408...129,855,202
G
Sec62
SEC62 homolog, preprotein translocation
decreases expression
ISO
kojic acid results in decreased expression of SEC62 mRNA
CTD
PMID:16595896
NCBI chr 3:30,847,025...30,875,412
Ensembl chr 3:30,847,024...30,875,412
G
Sectm1a
secreted and transmembrane 1A
decreases expression
ISO
kojic acid results in decreased expression of SECTM1 mRNA
CTD
PMID:16595896
NCBI chr11:120,958,221...120,988,023
Ensembl chr11:120,958,233...120,972,046
G
Septin7
septin 7
decreases expression
ISO
kojic acid results in decreased expression of SEPTIN7 mRNA
CTD
PMID:16595896
NCBI chr 9:25,163,287...25,219,867
Ensembl chr 9:25,163,735...25,219,867
G
Serpina5
serine (or cysteine) peptidase inhibitor, clade A, member 5
decreases expression
ISO
kojic acid results in decreased expression of SERPINA5 mRNA
CTD
PMID:16595896
NCBI chr12:104,065,572...104,072,397
Ensembl chr12:104,067,372...104,072,396
G
Shcbp1
Shc SH2-domain binding protein 1
increases expression
ISO
kojic acid results in increased expression of SHCBP1 mRNA
CTD
PMID:16595896
NCBI chr 8:4,785,976...4,829,549
Ensembl chr 8:4,785,976...4,829,567
G
Sin3b
transcriptional regulator, SIN3B (yeast)
decreases expression
ISO
kojic acid results in decreased expression of SIN3B mRNA
CTD
PMID:16595896
NCBI chr 8:73,449,898...73,484,831
Ensembl chr 8:73,449,913...73,484,829
G
Slc17a2
solute carrier family 17 (sodium phosphate), member 2
decreases expression
ISO
kojic acid results in decreased expression of SLC17A2 mRNA
CTD
PMID:16595896
NCBI chr13:23,990,924...24,009,174
Ensembl chr13:23,990,976...24,009,163
G
Slc25a2
solute carrier family 25 (mitochondrial carrier, ornithine transporter) member 2
decreases expression
ISO
kojic acid results in decreased expression of SLC25A2 mRNA
CTD
PMID:16595896
NCBI chr18:37,770,431...37,771,776
Ensembl chr18:37,770,431...37,771,776
G
Slc38a4
solute carrier family 38, member 4
decreases expression
ISO
kojic acid results in decreased expression of SLC38A4 mRNA
CTD
PMID:16595896
NCBI chr15:96,892,701...96,953,837
Ensembl chr15:96,892,701...96,953,837
G
Smc6
structural maintenance of chromosomes 6
decreases expression
ISO
kojic acid results in decreased expression of SMC6 mRNA
CTD
PMID:16595896
NCBI chr12:11,315,887...11,369,786
Ensembl chr12:11,315,887...11,369,786
G
Smim8
small integral membrane protein 8
decreases expression
ISO
kojic acid results in decreased expression of SMIM8 mRNA
CTD
PMID:16595896
NCBI chr 4:34,768,664...34,778,398
Ensembl chr 4:34,768,664...34,778,423
G
Snx10
sorting nexin 10
decreases expression
ISO
kojic acid results in decreased expression of SNX10 mRNA
CTD
PMID:16595896
NCBI chr 6:51,500,882...51,567,659
Ensembl chr 6:51,500,881...51,567,659
G
Soat2
sterol O-acyltransferase 2
increases expression
ISO
kojic acid results in increased expression of SOAT2 mRNA
CTD
PMID:16595896
NCBI chr15:102,058,853...102,071,871
Ensembl chr15:102,058,961...102,071,904
G
Sod1
superoxide dismutase 1, soluble
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD1 mRNA
CTD
PMID:18544905
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD2 mRNA
CTD
PMID:18544905
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Spata25
spermatogenesis associated 25
decreases expression
ISO
kojic acid results in decreased expression of SPATA25 mRNA
CTD
PMID:16595896
NCBI chr 2:164,669,302...164,670,454
Ensembl chr 2:164,668,309...164,670,457
G
Spp1
secreted phosphoprotein 1
increases expression
ISO
kojic acid results in increased expression of SPP1 mRNA
CTD
PMID:16595896
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Sptlc1
serine palmitoyltransferase, long chain base subunit 1
increases expression
ISO
kojic acid results in increased expression of SPTLC1 mRNA
CTD
PMID:16595896
NCBI chr13:53,486,784...53,531,401
Ensembl chr13:53,486,784...53,531,433
G
Srsf2
serine and arginine-rich splicing factor 2
increases expression
ISO
kojic acid results in increased expression of SRSF2 mRNA
CTD
PMID:16595896
NCBI chr11:116,740,723...116,744,511
Ensembl chr11:116,740,727...116,743,920
G
Ssxb5
SSX member B5
increases expression
ISO
kojic acid results in increased expression of SSX1 mRNA
CTD
PMID:16595896
NCBI chr X:8,669,930...8,676,348
Ensembl chr X:8,669,930...8,675,625
G
St13
suppression of tumorigenicity 13
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ST13 mRNA
CTD
PMID:18544905
NCBI chr15:81,247,869...81,284,278
Ensembl chr15:81,247,870...81,284,278
G
St18
suppression of tumorigenicity 18
decreases expression
ISO
kojic acid results in decreased expression of ST18 mRNA
CTD
PMID:16595896
NCBI chr 1:6,557,455...6,931,164
Ensembl chr 1:6,557,455...6,931,164
G
Stard8
StAR related lipid transfer domain containing 8
decreases expression
ISO
kojic acid results in decreased expression of STARD8 mRNA
CTD
PMID:16595896
NCBI chr X:98,046,539...98,118,334
Ensembl chr X:98,046,854...98,118,334
G
Stx6
syntaxin 6
increases expression
ISO
kojic acid results in increased expression of STX6 mRNA
CTD
PMID:16595896
NCBI chr 1:155,034,374...155,083,405
Ensembl chr 1:155,034,461...155,084,002
G
Sult1b1
sulfotransferase family 1B, member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1B1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1B1 mRNA
CTD
PMID:18544905
NCBI chr 5:87,661,186...87,686,054
Ensembl chr 5:87,661,198...87,686,054
G
Sult1c1
sulfotransferase family, cytosolic, 1C, member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C1 mRNA
CTD
PMID:18544905
NCBI chr17:54,268,643...54,297,659
Ensembl chr17:54,268,643...54,297,702
G
Sult1c2
sulfotransferase family, cytosolic, 1C, member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA
CTD
PMID:18544905
NCBI chr17:54,136,665...54,152,986
Ensembl chr17:54,136,665...54,153,367
G
Sult1e1
sulfotransferase family 1E, member 1
multiple interactions
EXP ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT1E1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1E1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Sult4a1
sulfotransferase family 4A, member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT4A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT4A1 mRNA
CTD
PMID:18544905
NCBI chr15:83,960,298...83,989,955
Ensembl chr15:83,960,298...83,989,955
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
decreases expression
ISO
kojic acid results in decreased expression of SUZ12 mRNA
CTD
PMID:16595896
NCBI chr11:79,883,932...79,924,949
Ensembl chr11:79,883,932...79,924,949
G
Swap70
SWA-70 protein
increases expression
ISO
kojic acid results in increased expression of SWAP70 mRNA
CTD
PMID:16595896
NCBI chr 7:109,820,890...109,882,720
Ensembl chr 7:109,820,918...109,882,713
G
Syf2
SYF2 homolog, RNA splicing factor (S. cerevisiae)
decreases expression
ISO
kojic acid results in decreased expression of SYF2 mRNA
CTD
PMID:16595896
NCBI chr 4:134,658,291...134,664,848
Ensembl chr 4:134,658,209...134,664,859
G
Sympk
symplekin
decreases expression
ISO
kojic acid results in decreased expression of SYMPK mRNA
CTD
PMID:16595896
NCBI chr 7:18,758,321...18,788,542
Ensembl chr 7:18,758,302...18,788,543
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
increases expression
ISO
kojic acid results in increased expression of SYNCRIP mRNA
CTD
PMID:16595896
NCBI chr 9:88,331,417...88,364,645
Ensembl chr 9:88,329,062...88,364,627
G
Taf15
TATA-box binding protein associated factor 15
decreases expression
ISO
kojic acid results in decreased expression of TAF15 mRNA
CTD
PMID:16595896
NCBI chr11:83,363,897...83,397,569
Ensembl chr11:83,363,912...83,397,569
G
Tal1
T cell acute lymphocytic leukemia 1
decreases expression
ISO
kojic acid results in decreased expression of TAL1 mRNA
CTD
PMID:16595896
NCBI chr 4:114,913,623...114,928,952
Ensembl chr 4:114,913,623...114,928,952
G
Tbxas1
thromboxane A synthase 1, platelet
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TBXAS1 mRNA
CTD
PMID:18544905
NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
G
Tcf21
transcription factor 21
decreases expression
ISO
kojic acid results in decreased expression of TCF21 mRNA
CTD
PMID:16595896
NCBI chr10:22,693,162...22,696,042
Ensembl chr10:22,693,180...22,696,073
G
Tent4b
terminal nucleotidyltransferase 4B
decreases expression
ISO
kojic acid results in decreased expression of TENT4B mRNA
CTD
PMID:16595896
NCBI chr 8:88,925,229...88,989,942
Ensembl chr 8:88,925,837...88,986,355
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TGFB1 mRNA
CTD
PMID:18544905
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Thrb
thyroid hormone receptor beta
decreases expression
ISO
kojic acid results in decreased expression of THRB mRNA
CTD
PMID:16595896
NCBI chr14:4,429,599...4,810,538
Ensembl chr14:4,431,611...4,809,435
G
Tie1
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
decreases expression
ISO
kojic acid results in decreased expression of TIE mRNA
CTD
PMID:16595896
NCBI chr 4:118,328,388...118,347,046
Ensembl chr 4:118,328,388...118,347,258
G
Tirap
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
decreases expression
ISO
kojic acid results in decreased expression of TIRAP mRNA
CTD
PMID:16595896
NCBI chr 9:35,095,687...35,111,587
Ensembl chr 9:35,095,847...35,111,587
G
Tmco5
transmembrane and coiled-coil domains 5
increases expression
ISO
kojic acid results in increased expression of TMCO5 mRNA
CTD
PMID:16595896
NCBI chr 2:116,709,174...116,722,987
Ensembl chr 2:116,709,172...116,722,975
G
Tmem217
transmembrane protein 217
increases expression
ISO
kojic acid results in increased expression of TMEM217 mRNA
CTD
PMID:16595896
NCBI chr17:29,744,983...29,768,567
Ensembl chr17:29,744,981...29,771,359
G
Tmem59l
transmembrane protein 59-like
decreases expression
ISO
kojic acid results in decreased expression of TMEM59L mRNA
CTD
PMID:16595896
NCBI chr 8:70,936,505...70,939,998
Ensembl chr 8:70,936,517...70,940,008
G
Tmx1
thioredoxin-related transmembrane protein 1
decreases expression
ISO
kojic acid results in decreased expression of TMX1 mRNA
CTD
PMID:16595896
NCBI chr12:70,499,928...70,514,398
Ensembl chr12:70,499,869...70,514,814
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNF mRNA
CTD
PMID:18544905
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip8l1
tumor necrosis factor, alpha-induced protein 8-like 1
decreases expression
ISO
kojic acid results in decreased expression of TNFAIP8L1 mRNA
CTD
PMID:16595896
NCBI chr17:56,469,439...56,491,249
Ensembl chr17:56,469,477...56,480,955
G
Tnfsf10
tumor necrosis factor (ligand) superfamily, member 10
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA
CTD
PMID:18544905
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
G
Tor4a
torsin family 4, member A
decreases expression
ISO
kojic acid results in decreased expression of TOR4A mRNA
CTD
PMID:16595896
NCBI chr 2:25,082,732...25,086,825
Ensembl chr 2:25,082,978...25,086,898
G
Tpcn1
two pore channel 1
increases expression
ISO
kojic acid results in increased expression of TPCN1 mRNA
CTD
PMID:16595896
NCBI chr 5:120,672,222...120,726,731
Ensembl chr 5:120,672,218...120,726,738
G
Tpst2
protein-tyrosine sulfotransferase 2
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA
CTD
PMID:17917374
NCBI chr 5:112,424,548...112,463,222
Ensembl chr 5:112,424,557...112,463,227
G
Tradd
TNFRSF1A-associated via death domain
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TRADD mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TRADD mRNA
CTD
PMID:18544905
NCBI chr 8:105,985,207...105,991,226
Ensembl chr 8:105,984,918...105,991,241
G
Tram1
translocating chain-associating membrane protein 1
decreases expression
ISO
kojic acid results in decreased expression of TRAM1 mRNA
CTD
PMID:16595896
NCBI chr 1:13,634,917...13,660,134
Ensembl chr 1:13,634,922...13,660,134
G
Tram2
translocating chain-associating membrane protein 2
decreases expression
ISO
kojic acid results in decreased expression of TRAM2 mRNA
CTD
PMID:16595896
NCBI chr 1:21,071,621...21,149,449
Ensembl chr 1:21,066,523...21,149,453
G
Trem1
triggering receptor expressed on myeloid cells 1
decreases expression
ISO
kojic acid results in decreased expression of TREM1 mRNA
CTD
PMID:16595896
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Trmt10c
tRNA methyltransferase 10C, mitochondrial RNase P subunit
decreases expression
ISO
kojic acid results in decreased expression of TRMT10C mRNA
CTD
PMID:16595896
NCBI chr16:55,854,083...55,858,149
Ensembl chr16:55,852,972...55,858,182
G
Trp53
transformation related protein 53
multiple interactions
ISO EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TP53 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trp53bp2
transformation related protein 53 binding protein 2
increases expression
ISO
kojic acid results in increased expression of TP53BP2 mRNA
CTD
PMID:16595896
NCBI chr 1:182,236,737...182,289,997
Ensembl chr 1:182,236,737...182,289,997
G
Tspan8
tetraspanin 8
increases expression
ISO
kojic acid results in increased expression of TSPAN8 mRNA
CTD
PMID:16595896
NCBI chr10:115,652,722...115,685,798
Ensembl chr10:115,652,737...115,685,798
G
Ttc9
tetratricopeptide repeat domain 9
increases expression
ISO
kojic acid results in increased expression of TTC9 mRNA
CTD
PMID:16595896
NCBI chr12:81,678,023...81,714,331
Ensembl chr12:81,678,023...81,714,331
G
Ttk
Ttk protein kinase
decreases expression
ISO
kojic acid results in decreased expression of TTK mRNA
CTD
PMID:16595896
NCBI chr 9:83,716,704...83,754,442
Ensembl chr 9:83,716,742...83,754,442
G
Tulp3
TUB like protein 3
decreases expression
ISO
kojic acid results in decreased expression of TULP3 mRNA
CTD
PMID:16595896
NCBI chr 6:128,298,103...128,332,833
Ensembl chr 6:128,298,124...128,332,814
G
Twf1
twinfilin actin binding protein 1
decreases expression
ISO
kojic acid results in decreased expression of TWF1 mRNA
CTD
PMID:16595896
NCBI chr15:94,475,829...94,487,727
Ensembl chr15:94,475,832...94,487,770
G
Tyr
tyrosinase
decreases activity increases expression
EXP ISO
kojic acid results in decreased activity of TYR protein kojic acid results in increased expression of TYR mRNA; kojic acid results in increased expression of TYR protein
CTD
PMID:23738040 PMID:27586645
NCBI chr 7:87,073,979...87,142,637
Ensembl chr 7:87,073,979...87,142,720
G
Tyrp1
tyrosinase-related protein 1
decreases expression
EXP
kojic acid results in decreased expression of TYRP1 protein
CTD
PMID:27586645
NCBI chr 4:80,752,360...80,769,973
Ensembl chr 4:80,752,360...80,769,956
G
Ube2d4
ubiquitin-conjugating enzyme E2D 4
decreases expression
ISO
kojic acid results in decreased expression of UBE2D4 mRNA
CTD
PMID:16595896
Ensembl chr15:58,718,439...58,719,170
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
decreases expression
ISO
kojic acid results in decreased expression of UBE2E1 mRNA
CTD
PMID:16595896
NCBI chr14:4,137,852...4,186,967
Ensembl chr14:4,137,837...4,186,974
G
Ube2m
ubiquitin-conjugating enzyme E2M
decreases expression
ISO
kojic acid results in decreased expression of UBE2M mRNA
CTD
PMID:16595896
NCBI chr 7:12,769,047...12,772,202
Ensembl chr 7:12,769,047...12,772,202
G
Ubr7
ubiquitin protein ligase E3 component n-recognin 7 (putative)
increases expression
ISO
kojic acid results in increased expression of UBR7 mRNA
CTD
PMID:16595896
NCBI chr12:102,724,234...102,743,960
Ensembl chr12:102,724,226...102,743,966
G
Ufd1
ubiquitin recognition factor in ER-associated degradation 1
increases expression
ISO
kojic acid results in increased expression of UFD1 mRNA
CTD
PMID:16595896
NCBI chr16:18,630,486...18,654,011
Ensembl chr16:18,630,529...18,654,011
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UGT1A2 mRNA
CTD
PMID:17917374
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Ugt1a6b
UDP glucuronosyltransferase 1 family, polypeptide A6B
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of UGT1A6 mRNA
CTD
PMID:18544905
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
G
Unc5c
unc-5 netrin receptor C
decreases expression
ISO
kojic acid results in decreased expression of UNC5C mRNA
CTD
PMID:16595896
NCBI chr 3:141,171,360...141,540,685
Ensembl chr 3:141,170,977...141,540,685
G
Ung
uracil DNA glycosylase
multiple interactions
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UNG mRNA
CTD
PMID:17917374
NCBI chr 5:114,268,427...114,277,382
Ensembl chr 5:114,268,447...114,277,384
G
Usp1
ubiquitin specific peptidase 1
decreases expression
ISO
kojic acid results in decreased expression of USP1 mRNA
CTD
PMID:16595896
NCBI chr 4:98,812,047...98,823,780
Ensembl chr 4:98,812,047...98,823,780
G
Usp44
ubiquitin specific peptidase 44
decreases expression
ISO
kojic acid results in decreased expression of USP44 mRNA
CTD
PMID:16595896
NCBI chr10:93,655,831...93,696,792
Ensembl chr10:93,667,417...93,693,950
G
Utp11
UTP11 small subunit processome component
increases expression
ISO
kojic acid results in increased expression of UTP11 mRNA
CTD
PMID:16595896
NCBI chr 4:124,571,173...124,587,395
Ensembl chr 4:124,571,953...124,587,393
G
Wnt10a
wingless-type MMTV integration site family, member 10A
decreases expression
ISO
kojic acid results in decreased expression of WNT10A mRNA
CTD
PMID:16595896
NCBI chr 1:74,831,178...74,843,335
Ensembl chr 1:74,830,675...74,843,338
G
Yeats2
YEATS domain containing 2
increases expression
ISO
kojic acid results in increased expression of YEATS2 mRNA
CTD
PMID:16595896
NCBI chr16:19,959,803...20,051,323
Ensembl chr16:19,959,813...20,051,323
G
Zc3h15
zinc finger CCCH-type containing 15
decreases expression
ISO
kojic acid results in decreased expression of ZC3H15 mRNA
CTD
PMID:16595896
NCBI chr 2:83,474,922...83,494,961
Ensembl chr 2:83,474,779...83,494,966
G
Zdhhc20
zinc finger, DHHC domain containing 20
decreases expression
ISO
kojic acid results in decreased expression of ZDHHC20 mRNA
CTD
PMID:16595896
NCBI chr14:58,070,159...58,128,288
Ensembl chr14:58,070,160...58,127,733
G
Zfand1
zinc finger, AN1-type domain 1
decreases expression
ISO
kojic acid results in decreased expression of ZFAND1 mRNA
CTD
PMID:16595896
NCBI chr 3:10,405,013...10,416,383
Ensembl chr 3:10,405,013...10,416,377
G
Zfp146
zinc finger protein 146
decreases expression
ISO
kojic acid results in decreased expression of ZNF146 mRNA
CTD
PMID:16595896
NCBI chr 7:29,859,912...29,869,225
Ensembl chr 7:29,860,694...29,869,175
G
Zfp414
zinc finger protein 414
decreases expression
ISO
kojic acid results in decreased expression of ZNF414 mRNA
CTD
PMID:16595896
NCBI chr17:33,848,066...33,850,690
Ensembl chr17:33,848,064...33,850,753
G
Zfp438
zinc finger protein 438
increases expression
ISO
kojic acid results in increased expression of ZNF438 mRNA
CTD
PMID:16595896
NCBI chr18:5,210,027...5,334,826
Ensembl chr18:5,210,029...5,334,807
G
Zkscan16
zinc finger with KRAB and SCAN domains 16
decreases expression
ISO
kojic acid results in decreased expression of ZNF483 mRNA
CTD
PMID:16595896
NCBI chr 4:58,943,568...58,962,624
Ensembl chr 4:58,943,628...58,958,355
G
Zkscan8
zinc finger with KRAB and SCAN domains 8
decreases expression
ISO
kojic acid results in decreased expression of ZKSCAN8 mRNA
CTD
PMID:16595896
NCBI chr13:21,697,391...21,715,284
Ensembl chr13:21,697,392...21,715,290
G
Zmynd15
zinc finger, MYND-type containing 15
decreases expression
ISO
kojic acid results in decreased expression of ZMYND15 mRNA
CTD
PMID:16595896
NCBI chr11:70,350,259...70,357,028
Ensembl chr11:70,350,259...70,357,028
G
Zp2
zona pellucida glycoprotein 2
decreases expression
ISO
kojic acid results in decreased expression of ZP2 mRNA
CTD
PMID:16595896
NCBI chr 7:119,725,985...119,744,514
Ensembl chr 7:119,725,995...119,744,514
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all